Intralesional immunotherapy for multiple recalcitrant plantar warts: Candida antigen is superior to intralesional purified protein derivative. 2022

Ahmad Nofal, and Lamiaa Adel, and Manal Fawzy, and Basma M Elkholy
Dermatology, Venereology and Andrology Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt.

Treatment of recalcitrant plantar warts represent a highly challenging issue for both patients and physicians. Candida antigen and purified protein derivative (PPD) have shown promising efficacy in the treatment of warts, however no previous studies have compared both antigens for recalcitrant plantar warts. To assess the efficacy and safety of intralesional Candida antigen versus intralesional PPD in the management of recalcitrant plantar warts. The study included 120 adult patients with multiple recalcitrant plantar warts. They were randomly assigned to one of three groups; Candida antigen, PPD, or normal saline. Injections into the largest wart were repeated every 2 weeks until clearance or for a maximum of five sessions. Complete wart clearance was reported in 33 patients (82.5%) of the Candida antigen group, in 22 patients (55.6%) of the PPD group, and in one patient (5%) of the control saline group. A statistically significant difference was found between the studied groups in favor of Candida antigen. Adverse effects were mild and insignificant in the three groups. Intralesional antigen immunotherapy by Candida antigen or PPD is a promising, safe, and cost-effective therapeutic option for multiple recalcitrant plantar warts, with statistically significant superiority of Candida antigen.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D002175 Candida A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; VULVOVAGINAL CANDIDIASIS; and CANDIDIASIS, ORAL (THRUSH). Candida guilliermondii var. nitratophila,Candida utilis,Cyberlindnera jadinii,Hansenula jadinii,Lindnera jadinii,Monilia,Pichia jadinii,Saccharomyces jadinii,Torula utilis,Torulopsis utilis,Monilias
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077330 Saline Solution A crystalloid solution that contains 9.0g of SODIUM CHLORIDE per liter of water. It has a variety of uses, including: as a CONTACT LENS SOLUTION, in OPHTHALMIC SOLUTIONS and NASAL LAVAGE, in wound irrigation, and for FLUID THERAPY. 0.9% NaCl,0.9% Saline,Normal Saline,Saline, 0.9%,Saline, Normal
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000946 Antigens, Fungal Substances of fungal origin that have antigenic activity. Fungal Antigen,Fungal Antigens,Antigen, Fungal
D014860 Warts Benign epidermal proliferations or tumors; some are viral in origin. Verruca,Verrucas,Wart
D015552 Injections, Intralesional Injections introduced directly into localized lesions. Intralesional Injections,Injection, Intralesional,Intralesional Injection
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Ahmad Nofal, and Lamiaa Adel, and Manal Fawzy, and Basma M Elkholy
January 2015, Pediatric dermatology,
Ahmad Nofal, and Lamiaa Adel, and Manal Fawzy, and Basma M Elkholy
September 2019, Dermatologic therapy,
Ahmad Nofal, and Lamiaa Adel, and Manal Fawzy, and Basma M Elkholy
June 2020, International journal of dermatology,
Ahmad Nofal, and Lamiaa Adel, and Manal Fawzy, and Basma M Elkholy
October 2022, Dermatologic therapy,
Ahmad Nofal, and Lamiaa Adel, and Manal Fawzy, and Basma M Elkholy
October 2021, Journal of cosmetic dermatology,
Ahmad Nofal, and Lamiaa Adel, and Manal Fawzy, and Basma M Elkholy
July 2020, Journal of the American Academy of Dermatology,
Ahmad Nofal, and Lamiaa Adel, and Manal Fawzy, and Basma M Elkholy
May 2022, Dermatology and therapy,
Ahmad Nofal, and Lamiaa Adel, and Manal Fawzy, and Basma M Elkholy
January 2003, Pediatric dermatology,
Ahmad Nofal, and Lamiaa Adel, and Manal Fawzy, and Basma M Elkholy
October 2019, Journal of the American Academy of Dermatology,
Ahmad Nofal, and Lamiaa Adel, and Manal Fawzy, and Basma M Elkholy
October 2019, Journal of the American Academy of Dermatology,
Copied contents to your clipboard!